We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Ultrasound Can Be Used as a Painless and Viable Alternative to Losing Weight

By HospiMedica International staff writers
Posted on 24 Feb 2015
A leading producer of aesthetic medical devices has developed the first noninvasive body contouring treatment approved by the United States Food and Drug Administration (FDA). More...
Most women are unhappy about their abdominal area, and the new treatment offers a safe and efficient treatment for reducing abdominal fat by an average of 3.3–6.35 cm.

The treatment makes use of pulsed focused ultrasound to precisely target subcutaneous fat, without heating it, while keeping blood vessels, nerves, muscles and other surrounding tissue intact. The treatment does not require any surgery, anesthetics, or recovery time, and targets fat deposits that are difficult to remove with diet, and exercise alone.

The treatment was developed by Syneron Medical (Irvine, CA, USA) and is called UltraShape. The treatment destroys fat cells by emitting acoustic waves of ultrasonic energy, and focusing them into a confined focal volume. UltraShape transmits pulsed ultrasound, which restricts temperature elevation to less than 0.5 °C increase. The treatment targets only subcutaneous fat at a known depth, and destroys fat instantly, and selectively.

Shimon Eckhouse, PhD, Chairman of the Board of Directors for Syneron Candela, stated, "UltraShape uses ultrasound technology that was perfected in 10 years of research and development by world leading scientists and doctors to noninvasively destruct fat without any damage to surrounding tissue. UltraShape efficiency in noninvasive fat destruction has been studied and proven in more than 13 clinical studies with more than 900 patients treated by this technology. These studies have also demonstrated the excellent safety record of the technology as well as its ability to do it with no downtime to the patient."

Related Links:

Syneron Medical
Ultrashape 



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.